搜索结果: 1-9 共查到“肿瘤病理学 MANAGEMENT”相关记录9条 . 查询时间(0.296 秒)
CHEMOTHERAPY AND BIOLOGICAL AGENTS IN THE CLINICAL MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
CHEMOTHERAPY BIOLOGICAL AGENTS
2015/3/20
Historically surgery and subsequently radiotherapy became established as the primary treatments for head and neck
squamous cell carcinoma. The significant incidence of recurrence and metastasis in pa...
ADVANCED NON-MELANOMA SKIN CANCERS OF THE HEAD AND NECK: AN OVERVIEW ON MANAGEMENT
MANAGEMENT Skin cancer
2015/3/20
Non-melanoma skin cancers occur at an epidemic rate in Australia and are increasing in incidence worldwide. In most
patients local treatment is curative. However, a subset of patients will be diagnos...
Developments in melanoma management – success and failure
success and failure melanoma management
2015/3/18
Melanoma is a high priority cancer in Australia with a lifetime risk of occurrence of 1 in 30. However the incidence rate rise is
stabilising and survival now exceeds 90%. The improvements in melanom...
Investigation and management of paraneoplastic neurological syndromes
Investigation management paraneoplastic neurological syndromes
2015/3/17
Paraneoplastic neurological syndromes (PNS) are rare, but severely debilitating complications of cancer. These disorders are a non-metastatic phenomenon and are considered to have an immune-mediated a...
MANAGEMENT OF WOMEN AT INCREASED GENETIC RISK OF OVARIAN CANCER
INCREASED GENETIC RISK MANAGEMENT
2015/3/13
Epidemiological studies have identified family history as one of
the major risk factors for epithelial ovarian cancer (subsequently
referred to as “ovarian cancer”) and in recent years we have
gain...
FDG PET: Revolution or evolution in the management of non-small cell lung cancer?
Revolution evolution management of non-small cell lung cancer
2015/3/11
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. In Australia there is a falling incidence in males that is not matched in females, t...
Contemporary management of non-small cell lung cancer in Australia
Contemporary management non-small cell lung cancer Australia
2015/3/11
In 1955, Bromley and Szur reported on 66 patients with a pathologic diagnosis of lung cancer who had been treated with high dose radiotherapy and who had then proceeded to surgery1. In 24 (46.7%) no t...
Management of Thyroid carcinoma:Hahnemann experience
Thyroid carcinoma Hahnemann experience
2010/1/4
The primary treatment of thyroid carcinoma is surgery and the outcome depends on its extent. The post-operative management alternatives in thyroid carcinoma include thyroid hormone, radio-iodine ablat...
Indicators of Quality Outcome for Management of Cancer Patients
Cancer Patients Quality Outcome
2015/3/9
Four authors in this issue of Cancer
Forum examine aspects of
improving quality in cancer care.
Quality in health care is not unique
in the diversity of terminology that divides its practitioners....